Endogenous nitric oxide synthesis inhibitor asymmetric dimethyl L-arginine accelerates endothelial cell senescence.
about
Statins as regulators of redox state in the vascular endothelium: beyond lipid loweringDimethylarginine dimethylaminohydrolase II overexpression attenuates LPS-mediated lung leak in acute lung injury.Oxidized low-density lipoprotein and ankle-brachial pressure index in patients with clinically evident peripheral arterial disease.The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular DiseaseProtecting against vascular disease in brainAsymmetric dimethylarginine (ADMA): the silent transition from an 'uraemic toxin' to a global cardiovascular risk molecule.Spotlight on endothelial progenitor cell inhibitors: short review.Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules.Regulation of DDAH1 as a Potential Therapeutic Target for Treating Cardiovascular Diseases.Vascular aging: chronic oxidative stress and impairment of redox signaling-consequences for vascular homeostasis and disease.Opposite associations of plasma homoarginine and ornithine with arginine in healthy children and adolescents.The use of surrogate vascular markers in youth at risk for premature cardiovascular disease.The emerging role of cardiovascular risk factor-induced mitochondrial dysfunction in atherogenesis.Podocyte dysfunction in aging--related glomerulosclerosis.Nitric oxide (NO) and asymmetric dimethylarginine (ADMA): their pathophysiological role and involvement in intracerebral hemorrhage.Cardiorenal syndrome: pathophysiology, preclinical models, management and potential role of uraemic toxins.Endothelial dysfunction and hypertension in aging.The hexacarbonyldicobalt derivative of aspirin acts as a CO-releasing NSAID on malignant mesothelioma cells.Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction in Patients With Breast Cancer.A relative L-arginine deficiency contributes to endothelial dysfunction across the stages of the menopausal transition.Modulation of vascular endothelial cell senescence by integrin β4.The role of actin depolymerizing factor in advanced glycation endproducts-induced impairment in mouse brain microvascular endothelial cells.Asymmetric dimethylarginine (ADMA) accelerates cell senescence.Association of the -449GC and -1151AC polymorphisms in the DDAH2 gene with asymmetric dimethylarginine and erythropoietin resistance in Chinese patients on maintenance hemodialysis.Time-effect relationship of extracts from ginseng, notoginseng and chuanxiong on vascular endothelial cells senescence.
P2860
Q26853120-2A634E9B-A157-487E-98A8-B4935B535C20Q33799650-35BDE26E-4591-4EB1-8286-789C44BBDE4AQ33822842-8D2561B8-9EFD-44F0-A46F-4F6D5368E2AEQ33940891-9BD160B7-5F91-43ED-BC93-02B1D3AFAD98Q34979773-0DA9F29B-4223-4276-8FDC-42A0EA2455CFQ36018553-2A90DA52-E105-41C1-BEC0-36D0D917D221Q36381012-7AA1F236-3733-4CE4-9EBE-16961FEB7D9EQ36957089-0783DE85-8A48-4E23-A658-920020FC38EAQ37009925-54A2E7D7-4DD7-4227-950F-2AE920498421Q37030271-072573C3-2D37-4591-BDDD-F5B39E02EA28Q37375385-3F10ECCD-A809-4763-B8A4-DDCF9EB41943Q37506346-51A3C5A7-7B89-4012-BF10-4213C1E4A45CQ37651334-9C8DDD3D-CCFC-4A32-9D12-276B4D54473BQ37881701-5761B267-BBC1-4AC6-97E6-55C1CBCB5FB8Q37888834-42AB93BC-D837-4A92-8B52-330DA4F1458FQ37947677-E62A39E5-4AB8-48B7-84F8-66E312307C06Q38042870-5A842C48-BEE2-4E46-A866-E1DFC8F95AF1Q39093077-756DFB44-F5BB-4045-9FFD-E66756C730F5Q40132680-BF3F6862-7B6A-4C7E-8C06-415BF6D8B8F5Q41037479-AC9D16FC-9D45-4F81-BDA6-427E3630EB59Q43051634-F9253933-9302-4993-AAA8-FF65EB5B61C7Q46389965-4FDE31C5-72C5-4350-BFE1-A54C9E589D41Q46917805-CE0EE083-71A4-4C89-A78C-2A0A833EEA87Q48313657-6969C4CC-3DDA-400C-8A69-F13624206942Q53030882-F3C25892-124C-4C99-BA49-19BC36F88DDC
P2860
Endogenous nitric oxide synthesis inhibitor asymmetric dimethyl L-arginine accelerates endothelial cell senescence.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Endogenous nitric oxide synthe ...... s endothelial cell senescence.
@en
Endogenous nitric oxide synthe ...... s endothelial cell senescence.
@nl
type
label
Endogenous nitric oxide synthe ...... s endothelial cell senescence.
@en
Endogenous nitric oxide synthe ...... s endothelial cell senescence.
@nl
prefLabel
Endogenous nitric oxide synthe ...... s endothelial cell senescence.
@en
Endogenous nitric oxide synthe ...... s endothelial cell senescence.
@nl
P2093
P1476
Endogenous nitric oxide synthe ...... s endothelial cell senescence.
@en
P2093
Bibiana Beckmann
Fortunato Scalera
Jens Martens-Lobenhoffer
Jürgen Borlak
Michael Täger
P304
P356
10.1161/01.ATV.0000141843.77133.FC
P407
P577
2004-08-12T00:00:00Z